BiVoCo health ventures
en
en
en
en
en
en
Date of Foundation
2021

BiVoCo health ventures

"Voice-activated wellness via telehealth solutions & fragrant biomarkers."

Contact

The Idea origin story

AromaSync combines fragrance therapy and technology to enhance well-being. Our app features an intuitive interface offering curated fragrances, with each scent designed to evoke specific emotions. Through our innovative vocal biomarker analysis, we identify your wellness state and recommend personalized fragrances tailored to you. Engage in a multisensory healing experience that fosters relaxation, focus, and balance; explore the AromaSync Gratitude Loop for continued well-being growth.

The Mission

Mission: To enable proactive wellbeing management utilizing fragrance therapy and vocal biomarker analysis. Vision: Revolutionize self-care by merging technology with the healing power of scent.

Clients

Ok

Problems we solve

Client’s problem

AromaSync offers a solution to the increasing demand for personalized wellness experiences. By interpreting unique vocal biomarkers, it allows users to identify and manage emotional states using curated fragrances, thereby promoting quality self-care practices.

Confirmation of problem

The actuality of the problem is confirmed by the fact that stress-related health issues and emotional well-being concerns are on the rise globally, impacting overall quality of life and productivity.

Solution

AromaSync is our solution—an app using fragrance therapy and voice analysis for personalized emotional health support.

Our technologies

This solution is based on technologies

AI, Vocal Biomarker Analysis, Mobile App Development, IoT Integration

How it works

Our solution analyzes vocal biomarkers to determine emotional states, then recommends personalized fragrances to enhance well-being.

Value for the client

AromaSync offers an immersive fragrance therapy experience, unlocking well-being through personalized scents based on vocal biomarker analysis.

Market and strategy

Market size

150

mln/year

We estimate the market size for which our solution is designed in monetary terms as follows

Market share goal

25

% of the market

Is our goal in the next 3 years

Team

My name’s

Domenic Minichiello

My key role in the product

My key role is Founder & CCO, responsible for setting company vision, strategizing growth plans and fostering brand innovation.

Team size and key members

BiVoCo's Strategic Advisory Team: from directors and strategists of business development, partnerships and finance, to technology innovators.

Competitors

Competitors

In addition to Sonde Health, BiAffect, Aromajoin and Moodo, other potential competitors could be established digital health platforms like Teladoc or Doctor on Demand that may expand into wellness tech. Companies specializing in AI-driven diagnostics such as Butterfly Network and Zebra Medical Vision could also enter the space. Furthermore, any business involved in voice analysis and/or wellness tech has the potential to become a competitor if it pivots its business model towards solutions similar to yours.

Our Advantages

AromaSync uniquely incorporates fragrance therapy with vocal biomarkers for holistic wellness. Leveraging AI, it offers personalized emotional insights and immersive sensory experiences, distinguishing itself in the wellness tech landscape.

Business model

AromaSync profits from in-app purchases, subscriptions, collaborations. Clients pay for personalized fragrances and enhanced features.

Traction

BiVoCo has hit a key milestone securing essential Sonde Health license. Two-thirds of AromaSync app development accomplished, reflecting our commitment to progression and innovation in partnership with Sonde Health.

BiVoCo has wrapped up app development, MVP testing and locked in partnerships. Next, extra funds will power marketing, user growth and scaling for steady expansion - setting AromaSync on course for triumph in wellness tech.

Metrics

BiVoCo's AromaSync is in the development phase, emphasizing fragrance recommendations and vocal biomarker analysis. We're committed to perfecting user experience for our expected audience upon launch.

Incorporation

Our company incorporated in

British Columbia, Canada

Key risks

The main risks could include potential inaccuracies in the vocal biomarker analysis technology, facing competition from similar wellness apps, sustaining user engagement over time, securing strategic partnerships and maintaining a consistent supply chain for the delivery of fragrances.

Investments

$

This is a joint venture with two companies. The parent companies I’ve raised about 2.5 million there’s been no funds raised for aromasync. We plan to raise $2.5m

We raised investments

Our Investors

Private investors in Snap Brands and T2D parent companies own shares in the BiVoCo health ventures joint venture, contributing to its growth and success of aromasync.

Rising Investments

$

2000000

Currently, we are raising investments

$

The pre-investment valuation of the BiVoCo joint venture is US$2.5 million.

Estimated pre-investment valuation of the company

Request additional information

We’re looking for a co-founders

Open positions

Article

Read

Additional information

BiVoCo Health Ventures drives personalized wellness through AromaSync. Using unique vocal biomarkers and fragrances, we enhance holistic health innovatively. Our distinct team and partnerships differentiate us in life transformation.

BiVoCo health ventures
MVP
Date of Foundation
2021